CJA
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Résumé de cet Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a scholarly reply
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Weinbroum, A. A.
Right arrow Articles by Szold, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Weinbroum, A. A.
Right arrow Articles by Szold, A.
Canadian Journal of Anesthesia 48:167-174 (2001)
© Canadian Anesthesiologists' Society, 2001

Regional Anesthesia and Pain

Dextromethorphan attenuation of postoperative pain and primary and secondary thermal hyperalgesia

Avi A. Weinbroum, MD*,§, Alexander Gorodezky, MD§, David Niv, MD{dagger}, Ron Ben-Abraham, MD*, Valery Rudick, MD§ and Amir Szold{ddagger}

* From the Post-Anesthesia Care
{dagger} and the Pain Control Units,
{ddagger} the Endoscopic Surgery Service
§ and the Department of Anesthesiology and Critical Care Medicine, Tel Aviv Sourasky Medical Center, and the Sackler Faculty of Medicine Tel Aviv University, Tel Aviv, Israel.

Address correspondence to: Dr. Avi A. Weinbroum, Director, Post Anesthesia Care Unit Tel Aviv Sourasky Medical Center, 6 Weizman Street, Tel Aviv 64239, Israel. Phone: +972-3-697-3237; Fax: +972-3-692-5749; E-mail: draviw{at}tasmc.health.gov.il

Purpose: To determine the effect of 90 mg dextromethorphan (DM) po vs placebo 90 min preoperatively, on the immediate and delayed postoperative course.

Methods: Thirty patients undergoing laparoscopic cholecystectomy or inguinal hernioplasty under general anesthesia were studied. Half (DM) received 90 mg dextromethorphan and half received placebo 90 min before anesthesia. Intravenous Patient Controlled Aanalgesia with morphine was available for two hours within a six-hour observation period; 75 mg diclofenac im prn was given later in PACU and on-ward (24 hr). Pain was assessed using the visual analogue scales. Thermal thresholds for cold and hot sensation and for pain (by limit method) were evaluated at the site of skin incision (primary-) and distantly (secondary hyperalgesia). Von Frey filaments were applied testing touch sensation. Sedation level and morphine consumption were also assessed in PACU.

Results: Demographic, surgical and perioperative parameters were similar; no untoward effects were encountered. Pain intensity and sedation were lower, and the feeling of well-being was greater, in the DM patients: one vs five (median), two vs five, five vs two, respectively, P <0.01 (90 min time-point). Thermal application revealed absence of primary and secondary hyperalgesia only in the DM patients; von Frey filaments induced similar pain sensation in both groups. Mean morphine/group, morphine/weight and diclofenac injection rates were ~55% lower in the DM group: 2.1 ± 1.2 (SD) vs 4.7 ± 2.3, 0.03 ± 0.02 vs 0.07 ± 0.03, 1.0 ± 0.3 vs 2.4 ± 0.2, respectively, P <0.01.

Conclusions: Compared with placebo, DM enabled reduction of postoperative analgesics consumption, improved well-being, and reduced sedation, pain intensity and primary and secondary thermal hyperalgesia.




This article has been cited by other articles:


Home page
Journal of Pharmacy PracticeHome page
R. Leonard and H. Kourlas
Too Much of a Good Thing? Treating the Emerging Syndrome of Opioid-Induced Hyperalgesia
Journal of Pharmacy Practice, April 1, 2008; 21(2): 165 - 168.
[Abstract] [PDF]


Home page
Anesth. Analg.Home page
P. F. White
The Changing Role of Non-Opioid Analgesic Techniques in the Management of Postoperative Pain
Anesth. Analg., November 1, 2005; 101(5S_Suppl): S5 - 22.
[Abstract] [Full Text] [PDF]


Home page
Anesth. Analg.Home page
A. A. Weinbroum, B. Bender, A. Nirkin, S. Chazan, I. Meller, and Y. Kollender
Dextromethorphan-Associated Epidural Patient-Controlled Analgesia Provides Better Pain- and Analgesics-Sparing Effects than Dextromethorphan-Associated Intravenous Patient-Controlled Analgesia After Bone-Malignancy Resection: A Randomized, Placebo-Controlled, Double-Blinded Study
Anesth. Analg., March 1, 2004; 98(3): 714 - 722.
[Abstract] [Full Text] [PDF]


Home page
Br J AnaesthHome page
D. M. A. Choi, A. P. Kliffer, and M. J. Douglas
Dextromethorphan and intrathecal morphine for analgesia after Caesarean section under spinal anaesthesia
Br. J. Anaesth., May 1, 2003; 90(5): 653 - 658.
[Abstract] [Full Text] [PDF]


Home page
Ann. Surg. Oncol.Home page
R. B. Abraham, N. Marouani, and A. A. Weinbroum
Dextromethorphan Mitigates Phantom Pain in Cancer Amputees
Ann. Surg. Oncol., April 1, 2003; 10(3): 268 - 274.
[Abstract] [Full Text] [PDF]


Home page
Anesth. Analg.Home page
A. A. Weinbroum
A Single Small Dose of Postoperative Ketamine Provides Rapid and Sustained Improvement in Morphine Analgesia in the Presence of Morphine-Resistant Pain
Anesth. Analg., March 1, 2003; 96(3): 789 - 795.
[Abstract] [Full Text] [PDF]


Home page
Anesth. Analg.Home page
A. A. Weinbroum
Dextromethorphan Reduces Immediate and Late Postoperative Analgesic Requirements and Improves Patients' Subjective Scorings After Epidural Lidocaine and General Anesthesia
Anesth. Analg., June 1, 2002; 94(6): 1547 - 1552.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2001 by the Canadian Anesthesiologists' Society.